Beta Bionics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +3.5% | +2.3% | +6.8% | -14.0% | +14.2% | +8.1% | +4.6% | +36.9% | +5.6% | +13.3% | – | |
| – | +24.5% | -13.9% | +10.5% | +31.8% | -21.5% | +80.8% | +71.1% | -6.7% | -3.9% | +25.6% | +29.8% | – | |
| – | – | – | – | – | – | – | – | – | -522.1% | – | – | – | |
| – | – | +29.7% | +24.9% | +278.9% | -70.8% | -40.6% | +434.2% | -27.9% | +48.4% | -27.6% | -24.5% | – | |
| – | – | – | -56.8% | +361.9% | -294.6% | +503.9% | – | +53.7% | -93.1% | +3,219.0% | +23.3% | – | |
| – | – | -33.3% | -1,883.3% | +999.1% | – | +271.1% | -100.0% | +6,216.7% | -60.0% | -41.2% | +189.1% | – | |
| – | – | – | – | – | +190.9% | -7.2% | -161.4% | – | -302.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.